The College is pleased to announce that Mitchell Grayson, MD, FACAAI has been selected as the next Editor-in-Chief of Annals of Allergy, Asthma and Immunology. Dr. Grayson was selected from among many qualified candidates.
Dr. Grayson is Professor of Pediatrics and Chief of the Division of Allergy and Immunology at Nationwide Children’s Hospital and The Ohio State University. He is the Grant Morrow, III, MD endowed chair in pediatric research. Dr. Grayson has been a College member since 1995.
He has published more than 100 peer-reviewed articles, and has trained more than 20 graduate, post-doctoral or clinical research fellows. He is a board-certified diplomate of the American Board of Allergy and Immunology.
Dr. Grayson will begin working with current Editor-in-Chief, Gailen D. Marshall, MD, PhD, FACAAI this summer and will officially assume the EIC role on January 1, 2022.
“I am humbled and honored for this opportunity,” said Dr. Grayson. “Annals is truly an outstanding journal, and I am ever thankful for Dr. Marshall’s leadership and the excellent work he and his editorial team have provided. I look forward to building upon their successes, continuing the journey to increase the impact of Annals and making it the most useful and trusted “Clinician’s Journal” in allergy and immunology.”
Dr. Grayson’s scholarly achievement, experience in research design and organization skills, in addition to his years on the Annals editorial board, made him an excellent choice for Editor-in-Chief.
“I was extremely pleased when Dr. Grayson was selected for this position,” said Dr. Marshall. “Mitch Grayson is the ideal combination of critical thinker, accomplished investigator, model clinician and consensus builder to take over the leadership reins of our journal. He will lead the Annals in being ever more influential as a scholarly source while preserving the primary focus towards the practicing allergist-immunologist.”
The Editor-in-Chief is tasked with enhancing Annals’ reputation and leading the publication in new strategic directions. In addition, this leadership position is responsible for clinical and scientific aspects of the publication and management of the designated editorial office staff.
